Abstract
ADP-ribosylation factors (ARF) are GTPases that act to control the activation of numerous signaling events and cellular responses. The ARF6 isoform, present at the plasma membrane, can be activated by the angiotensin II type 1 receptor (AT1R), a process dependent upon β-arrestin recruitment to the activated receptor. Here, we describe classical methods used to assess β-arrestin-dependent activation of ARF6 following agonist stimulation of cells. In addition, because ARF6 and β-arrestin can form a complex, we describe the procedures used to detect the interaction of β-arrestin with this GTPase.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boulay PL, Cotton M, Melancon P, Claing A (2008) ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. J Biol Chem 283(52):36425–36434
Hashimoto S, Hirose M, Hashimoto A, Morishige M, Yamada A, Hosaka H, Akagi K, Ogawa E, Oneyama C, Agatsuma T, Okada M, Kobayashi H, Wada H, Nakano H, Ikegami T, Nakagawa A, Sabe H (2006) Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 103(18):7036–7041
Galas MC, Helms JB, Vitale N, Thierse D, Aunis D, Bader MF (1997) Regulated exocytosis in chromaffin cells. A potential role for a secretory granule-associated ARF6 protein. J Biol Chem 272(5):2788–2793
Mitchell R, Robertson DN, Holland PJ, Collins D, Lutz EM, Johnson MS (2003) ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor. J Biol Chem 278(36):33818–33830
Cohen LA, Honda A, Varnai P, Brown FD, Balla T, Donaldson JG (2007) Active Arf6 recruits ARNO/cytohesin GEFs to the PM by binding their PH domains. Mol Biol Cell 18(6):2244–2253
Poupart ME, Fessart D, Cotton M, Laporte SA, Claing A (2007) ARF6 regulates angiotensin II type 1 receptor endocytosis by controlling the recruitment of AP-2 and clathrin. Cell Signal 19(11):2370–2378
Charles R, Namkung Y, Cotton M, Laporte SA, Claing A (2015) Betaarrestin-mediated angiotensin II signaling controls the activation of ARF6 and endocytosis in migration of vascular smooth muscle cells. J Biol Chem 291(8):3967–3981
Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT, Lefkowitz RJ (2001) Beta arrestin-mediated ARF6 activation and beta2-adrenergic receptor endocytosis. J Biol Chem 276(45):42509–42513
Benard V, Bohl BP, Bokoch GM (1999) Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 274(19):13198–13204
Boman AL, Zhang C, Zhu X, Kahn RA (2000) A family of ADP-ribosylation factor effectors that can alter membrane transport through the trans-Golgi. Mol Biol Cell 11(4):1241–1255
Dell’Angelica EC, Puertollano R, Mullins C, Aguilar RC, Vargas JD, Hartnell LM, Bonifacino JS (2000) GGAs: a family of ADP ribosylation factor-binding proteins related to adaptors and associated with the Golgi complex. J Cell Biol 149(1):81–94
Acknowledgments
This work was supported by the Canadian Institutes of Health Research (MOP-79470 and MOP-106596 to AC).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Charles, R., Bourmoum, M., Campbell, S., Claing, A. (2019). Methods to Investigate the β-Arrestin-Mediated Control of ARF6 Activation to Regulate Trafficking and Actin Cytoskeleton Remodeling. In: Scott, M., Laporte, S. (eds) Beta-Arrestins. Methods in Molecular Biology, vol 1957. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9158-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9158-7_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9157-0
Online ISBN: 978-1-4939-9158-7
eBook Packages: Springer Protocols